1
). The function of the proteasome and the process by which it is assembled have been extensively investigated [2] [3] [4] . Several chaperones that efficiently and accurately mediate proteasome assembly have been identified 5 . In particular, the assembly of regulatory particles is tightly orchestrated by specific chaperones. There are three regulatory particle assembly intermediates, with specific base subunits and dedicated chaperones (Nas6, Rpn14, Adc17 and Hsm3) [6] [7] [8] . Genetic studies have indicated that the formation of the intermediary tetrameric base complex, consisting of Rpt1-Rpt2-Rpn1 with the Hsm3 chaperone, is critical for proteasome regulatory particle assembly 6, 7, 9, 10 . Despite the large number of studies on proteasome assembly and the characterization of intermediates and chaperones, we are far from having a full understanding of how the proteasome is formed in vivo, and how this process is regulated. As with all protein complexes, in principle subunits can assemble after synthesis is completed, either per se or with the help of chaperones. In addition, they can assemble co-translationally, with one subunit associating with its partner protein as it is being synthesized at the ribosome, as soon as the interaction domain has been fully produced and folded 11 ; this type of assembly is thought to be widespread 12, 13 . One subunit of the Ccr4-Not complex, Not4, was reported to be important for the functional integrity and assembly of the proteasome 14 . The Ccr4-Not complex is a conserved multi-protein complex that regulates gene expression at all stages 15, 16 . It is built on a central scaffold protein, Not1, on which several different functional modules assemble 17 . A recent study has indicated that Ccr4-Not contributes to co-translational assembly of the Spt-Ada-Gcn5-acetyltransferase histone 18 . This reported role of the Ccr4-Not complex and the observed importance of Not4 for proteasome assembly led us to investigate whether proteasome assembly might be regulated during translation, and whether this was connected to Ccr4-Not.
Here we show that an essential step in eukaryotic proteasome base assembly is the co-translational association of the base subunits Rpt1 and Rpt2, and we provide evidence that this occurs in types of bodies that we call Not1-containing assemblysomes (NCA).
Results
Ribosome pausing during translation of RPT1 and RPT2. We performed a ribosome-profiling experiment in yeast to obtain information on the translation of proteasome mRNAs ( Supplementary  Fig. 1a-c) . We noted that two proteasome mRNAs, RPT1 and RPT2, encoding two base subunits, showed an accumulation of ribosome footprints at a specific codon (Fig. 1a) . These RPT1 and RPT2 footprint peaks were amongst the most important, genome-wide (Supplementary Fig. 1d ; algorithm to identify key peaks in ribosome-profiling data is described in Methods). This led us to focus on the position of the footprint peaks on RPT1 and RPT2. For both mRNAs, the peak corresponded to a proline codon (CCA) in the A-site of the ribosomes providing the footprint. In both cases, an aspartate codon was in the P-site of the ribosomes providing the footprint peak. Previous work has indicated that proline codons play a major role in stalling translation 19 and that ribosome pausing occurs at DP codon pairs particularly under limiting eIF5A 20 . Hence, our observations were consistent with substantial ribosome pausing during translation of RPT1 and RPT2. Interestingly, for both mRNAs, the P-site codon on which ribosomes were pausing was located just before the sequences encoding the AAA-ATPase domains of both proteins (Fig. 1a) .
Previous studies have indicated that Rpt1 and Rpt2 exhibit weak affinity for each other when synthesized separately and mixed; in addition, they are almost completely insoluble when bacterially expressed 21 . Moreover, they do not interact by the yeast two-hybrid method 22 . Thus, we considered that RPT1 and RPT2 translation might occur with pausing of ribosomes to allow co-translational assembly of the two proteins. Between 25 and 38 amino acids of a newly synthesized protein are known to occupy the ribosome tunnel 23 . Hence, the nascent peptide exposed from ribosomes paused on RPT2 mRNA at codon 165 (Fig. 1a) should include the α -helix formed by amino acids 75-100; in the mature proteasome, this Rpt2 helix interacts with a helix of Rpt1 (amino acids 49-75) 24 ( Fig. 1b) . That same α -helix of Rpt1 is exposed from ribosomes paused on codon 241 of RPT1 mRNA (Fig. 1a) . Thus, pausing of ribosomes on RPT1 and on RPT2 could indeed allow co-translational assembly of those two proteasome subunits via their N-terminal α -helices (Fig. 1c) .
Expression of stalled ribosome-associated nascent Rpt1 and Rpt2 chains. We created plasmids expressing different derivatives of Rpt1 and Rpt2 (Fig. 1d ) to test the idea that ribosome pausing during translation of RPT1 and RPT2 allows the co-translational assembly of their encoded N-terminal domains. The first plasmid allowed expression from the CUP1 promoter of a Rpt1-ribosome-associated nascent chain (Rpt1-RNC) similar to that expected to occur in vivo on ribosome pausing. This was achieved 
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ProtA-Rpt1-DP are depicted in red and green below the footprints, with amino acid numbers marked. The length of the vertical lines is proportional to the number of times a footprint was found at that location. We indicate below the footprint profiles the codons at the P-sites (D241 for RPT1 and D165 for RPT2) and A-sites (P242 for RPT1 and P166 for RPT2) of the ribosomes paused at the major pause sites, and we indicate the D135 codon for RPT1 where a minor accumulation of footprints is detected. b, Partial view of the structure of the proteasome regulatory particle (RP) (PDB 5A5B 24 ), showing the Rpt1 and Rpt2 subunits. The helices of Rpt1 and Rpt2 that interact are shown in red and green, respectively. c, Model of co-translational assembly of protein domains. d, Cartoon representation of the different Rpt1 and Rpt2 constructs used in this work.
by inserting a stretch of 12 lysine codons (K12) after codon 135 of RPT1, as previous work has indicated that stretches of lysines will provoke ribosome stalling 25 . We chose codon 135 because it corresponded to the first visible peak of ribosome pausing on the endogenous mRNA (see Fig. 1a ), and translation stalled at codon 135 would provide a ribosome-associated nascent Rpt1 peptide whose α -helix (amino acids 49-75) interacting with Rpt2 should be exposed from the ribosome tunnel. We made a similar plasmid for RPT2 (Rpt2-RNC), in which we inserted a stretch of 12 lysine codons after codon 165, the major ribosome pause site according to ribosome profiling (Fig. 1a) . Translation stalled at codon 165 would provide a ribosome-associated nascent Rpt2 peptide, whose Rpt1-interacting helix (amino acids 75-100) should be exposed from the ribosome tunnel.
The Rpt1-and Rpt2-RNCs were detectable as proteins of slightly more than 35 kDa (Fig. 2a) , larger than the expected sizes if translation had stalled exactly at the first lysine of K12 (approximately 19 kDa for Rpt1 and 22 kDa for Rpt2). This was also larger than expected if translation did not stall, and continued to a stop codon in any reading frame (48 codons in the same reading frame, 82 or 18 in the other reading frames). The apparent larger size of the nascent Rpt1 and Rpt2 peptides could be a result of post-translational modifications.
Paused ribosomes producing Rpt1 associate in dense bodies. Although both Rpt1 and Rpt2 nascent proteins were stable (Fig. 2a) , ribosome stalling is expected to provoke ribosome-associated quality control mechanisms that recycle ribosomes and efficiently degrade nascent protein and mRNA 26 . Consistent with this expectation, several RNCs of the same length and expressed from the same plasmids were not stable (see examples in Supplementary  Fig. 2a ). The stability of Rpt1 and Rpt2 RNCs might be a feature favorable and necessary for co-translational association of the nascent peptides.
To confirm that our constructs were producing RNCs, we analyzed their sedimentation in sucrose gradients. For Rpt1-RNC, we detected the nascent Rpt1 peptide in monosome and polysome fractions (Fig. 2b , left panel, fractions labeled M and P1, respectively). This suggested that the nascent Rpt1 is associated with ribosomes in an Rpt1-RNC. To confirm this, we treated extracts from cells expressing Rpt1-RNC with ethylenediaminetetraacetic acid (EDTA) to separate 40S and 60S ribosome subunits before sucrose gradient fractionation. After EDTA treatment, although the nascent peptide was partly detected in free fractions (denoted by F), it was also present in heavy fractions of the sucrose gradient (Fig. 2b, right panel, + EDTA, fraction P1). Ribosomal protein Rpl35 was used to track the ribosome content of the fractions, and was undetectable 25 ∆N-Rpt1-RNC in fraction P1 after EDTA treatment. Hence, the nascent Rpt1 peptide was associated in heavy bodies different from polysomes after EDTA treatment. We also prepared extracts in the presence of cycloheximide (CHX) to better preserve polysomes, and then treated extracts with RNase A before sucrose gradient sedimentation: Rpt1-RNC was still detected in heavy fractions (Fig. 2c , fraction P2) where Rpl35 was mostly no longer detected.
We then analyzed the sedimentation profile of Rpt2-RNC. Similar to Rpt1-RNC, it was detected throughout the sucrose gradient, including in the heavy fractions, suggesting that it is ribosomeassociated ( Supplementary Fig. 2b , left panels). It was also detected in free fractions of the sucrose gradient ( Supplementary Fig. 2b , left panel, fraction denoted by F), indicating that some of the peptide was not ribosome-associated. Nevertheless the sedimentation pattern of Rpt2-RNC was different to that of a similar Rpt2 1-166 fragment expressed from a plasmid without K12 and with, instead, a stop codon (HA-Rpt2 1-166 , Fig. 1d ), which was not detected in polysome fractions ( Supplementary Fig. 2c ).
An in-frame V5 epitope is present in our constructs between the K12 sequence and a stop codon (Fig. 1d) . Given that we did not know where ribosomes had stalled relative to the K12 sequence, we tested whether the V5 epitope was present in Rpt1-and Rpt2-RNCs. This was the case for some Rpt2-RNCs, but not for Rpt1-RNC ( Supplementary Fig. 2d ). It was mostly Rpt2-RNC in the free fractions of the sucrose gradient that was detectable with antibodies to V5 ( Supplementary Fig. 2b , right upper panels, comparing Flag and V5 signals), suggesting that this Rpt2 might have been produced by translation elongation to the stop codon followed by peptide release.
N-terminal domains of Rpt1 and Rpt2 are important for efficient ribosome pausing and formation of heavy soluble particles. Rpt1 and Rpt2, similar to all six proteasome base subunits, have an N-terminal domain predicted to be highly disordered 27 . We tested the importance of the N-terminal domain of Rpt1 in regard to the formation of Rpt1-RNC heavy particles by deleting the first 48 amino acids of Rpt1 (Δ N-Rpt1-RNC, Fig. 1d ). This Δ N-Rpt1-RNC construct was well expressed, but was mostly detected in free (F) and monosome (M) fractions after sedimentation on a sucrose gradient, and less so in polysomes (P1 or P2) compared with Rpt1-RNC (compare Fig. 2d and Fig. 2c , left panel, and see quantification in Fig. 2e ). Some Δ N-Rpt1-RNC in the total extract was detected by immunoblotting with antibodies to V5. It was mostly the Δ N-Rpt1-RNC in the free fractions after sucrose gradient sedimentation (Fig. 2d ) that might have been produced by translation elongation to the stop codon. These findings suggest that, for Rpt1-RNC, the N-terminal domain of Rpt1 contributed to efficient ribosome pausing and incorporation in heavy particles.
We similarly tested an Rpt2-RNC lacking the first 48 amino acids of Rpt2 (Δ N-Rpt2-RNC, Fig. 1d ). The level of the Δ N-Rpt2-RNC in soluble extracts was reduced compared with the Rpt2-RNC ( Supplementary Fig. 2b , compare TE lanes in left panels), despite being expressed at higher levels ( Supplementary Fig. 2e ). This indicates that for the Rpt2-RNC, the N-terminal domain of Rpt2 was necessary for solubility. The sedimentation pattern of the Δ N-Rpt2-RNC was similar to that of the Rpt2-RNC ( Supplementary Fig. 2b , right panels).
We created plasmids that expressed either the full-length Rpt1 or the N-terminally deleted Rpt1 under the CUP1 promoter (HA-Rpt1 and HA-Δ N-Rpt1, Fig. 1d ), and tested whether these could complement deletion of the endogenous gene in a plasmid shuffle assay. The Rpt1 derivatives were similarly expressed ( Supplementary  Fig. 2f ), but only the full-length HA-Rpt1 could complement the null mutant (Fig. 2f) . Hence, the N-terminal domain of Rpt1 is important for Rpt1 function.
Rpt1 and Rpt2 interact with their nascent partner stalled at the ribosome. If Rpt1 and Rpt2 assemble co-translationally, we expect that the full-length proteins should associate when coexpressed as nascent proteins stalled at the ribosome. To test this prediction, we coexpressed full-length Rpt1 (HA-Rpt1, Fig. 1d ) with the Rpt2-RNC, and full-length Rpt2 with the Rpt1-RNC (HA-Rpt2, Fig. 1d ). We fractionated total extracts on sucrose gradients and detected the full-length proteins and RNCs in the heavy fractions of the sucrose gradient (Fig. 3a) . We pooled the polysome fractions and immunoprecipitated the full-length proteins or the RNCs, finding that the partner RNC or full-length protein co-immunoprecipitated (Fig. 3b) .
To investigate how the endogenous proteasome subunits could affect association of the plasmid-encoded subunits, we isolated Rpn11 (a component of the 19S lid) from cells expressing full-length HA-Rpt1 and the Rpt2-RNC or full-length HA-Rpt2 and the Rpt1-RNC from episomes, or carrying empty plasmids as a control. After copper induction, Rpt2-and Rpt1-RNCs were monitored with antibodies and found to be expressed at levels similar to the endogenous proteins ( Supplementary Fig. 3a , second TE lane and Supplementary Fig. 3d , first TE lane, respectively). However, only very low levels of RNCs were detected in the Rpn11 purifications ( Supplementary Fig. 3 , first and second eluate lanes), whereas the same amount of endogenous Rpt1 and Rpt2 co-purified in all cases ( Supplementary Fig. 3 , comparison of all eluate lanes). Similarly, very little HA-Rpt1 ( Supplementary Fig. 3b , second eluate lane) or HA-Rpt2 (Supplementary Fig. 3a and Supplementary Fig. 3b , first eluate lane) co-purified with Rpn11. Hence, it seems unlikely that the endogenous subunits could be scaffolding the interaction of the episomally expressed proteasome subunits under the conditions of these experiments, with short (10 min) copper induction ( Fig. 3) , probably because most endogenous proteins are stably incorporated into proteasome complexes.
Full-length Rpt1 and Rpt2 in Not1-containing heavy particles.
The results presented above show that stable Rpt1-and Rpt2-RNCs were present in heavy bodies, allowing recruitment of the partner subunit to the stalled nascent peptide. We tested whether the scaffold of the Ccr4-Not complex, Not1, was a component of these bodies, as previous studies have indicated that the Ccr4-Not complex is important for proteasome assembly 14 . We prepared extracts from cells expressing Rpt2-RNC and full-length HA-Rpt1, treated them with EDTA, and separated them on a sucrose gradient. The heavy fractions P1 and P2 were pooled and, as expected, contained full-length HA-Rpt1 and Rpt2-RNC that co-immunoprecipitated (Fig. 3c ). Not1 was detected in these pooled heavy fractions, and it also co-immunoprecipitated with Rpt2-RNC and full-length HA-Rpt1 (Fig. 3c) .
We next questioned whether newly produced full-length HA-Rpt1 and/or HA-Rpt2, synthesized with ribosome pausing and transiently producing RNCs, would be detectable in heavy particles in the absence of coexpressed artificial RNC. We separated extracts from cells expressing the full-length HA-Rpt1 or HA-Rpt2 on sucrose gradients, with or without previous treatment of extracts with EDTA. HA-Rpt1 and HA-Rpt2 were both detected in the heavy fractions of the sucrose gradient before EDTA treatment, and also after EDTA treatment although to a lesser extent, as was Not1 (Fig. 4a,b) . Other proteins induced from the same CUP1 promoter, including other proteasome subunits such as the core protein subunit HA-Pup2, were not detected in heavy fractions of the sucrose gradient and their production was not accompanied by a similar induction of Not1 in these heavy fractions (Fig. 4c) .
Although both HA-Rpt1 and HA-Rpt2, expressed without co-induction of their partner, were detected in dense fractions of the sucrose gradient, both proteins turned over rapidly (Fig. 5a,b) .
Codons DP at the pause site are critical for Rpt1-Rpt2 interaction. To determine whether co-induced full-length Rpt1 and Rpt2 would associate, we cloned Flag-tagged versions of each protein under the CUP1 promoter (Flag-Rpt1 and Flag-Rpt2, Fig. 1d ) and coexpressed each with the HA-tagged version of the partner subunit. We observed efficient co-immunoprecipitation of FlagRpt1 with HA-Rpt2 and vice versa ( Supplementary Fig. 4a ), and Not1 also co-immunoprecipitated ( Supplementary Fig. 4a ).
We next tested the stability of full-length HA-Rpt2 induced in cells in which Protein A-tagged Rpt1 (ProtA-Rpt1-DP, Fig. 1d ) was expressed from a plasmid from Rpt1's own promoter to complement the deletion of the endogenous RPT1 gene (Fig. 5c ). HA-Rpt2 was more stable in those cells than in cells expressing endogenous Rpt1 from the genome (Fig. 5b) . This allowed us to use this setup to test the importance of the codons at the pause site of RPT1 for interaction of Rpt1 with Rpt2.
We mutated RPT1 Asp241 (GAT) and Pro242 (CCA) codons at the major ribosome-pausing site to Ala codons (GCG and GCG) in the plasmid expressing Protein A-tagged Rpt1 (ProtA-Rpt1-AA, Fig. 1d ). Residues Asp241 and Pro242 are located in a flexible linker that connects the Rpt1 OB and AAA domains (Fig. 1a) . Both side chains are solvent exposed and located on the side opposite to the Rpt2 interaction surface. Thus, a DP to AA mutation should affect neither Rpt1 protein structure nor its direct interaction with Rpt2. Consistently, codon-changed Rpt1 was able to complement the deletion of the RPT1 gene, even in the context of an RPN4 deletion, and when tested on medium with translation inhibitors and amino acid analogs on which proteasome mutants did not grow ( Supplementary Fig. 4b ).
The codon-changed ProtA-Rpt1 was expressed similarly to the WT Rpt1, except that a shorter form of the protein, consistently detected for WT ProtA-Rpt1-DP by immunoblotting, was not detectable in the AA mutant (Fig. 5d ). This observation is consistent with the shorter form of ProtA-Rpt1 being the nascent protein expressed from ribosomes paused at the DP site, and with the codon change to AA having abolished ribosome pausing. We next tested the stability of HA-Rpt2 in the presence of WT (DP) or AA ProtA-Rpt1, and found that codon-changed Rpt1 was less effective in stabilizing Rpt2 (Fig. 5e) . The difference in stability of HA-Rpt2 expressed with ProtA-Rpt1-DP compared with ProtA-Rpt1-AA was mild, but reproducible and significant. These results are consistent with ribosome pausing at the Rpt1 DP codons contributing to productive association of Rpt1 and Rpt2.
Interaction of the Rpt1 and Rpt2 N-terminal domains alleviates ribosome pausing. Previous studies have proposed that the Hsm3 chaperone scaffolds the association of Rpt1 and Rpt2, as it associates with the C-terminal domain of Rpt1 10, 28 and can also interact with Rpt2 28 , most probably with its AAA-ATPase domain 21 . Instead, our data suggest that co-translational association of nascent Rpt1 and Rpt2 underlies their productive association. To confirm that ribosome-associated nascent Rpt1 can interact with Rpt2 independently of Hsm3, we created a plasmid expressing an Rpt2 N-terminal fragment that included the Rpt1-interacting helix but lacked the Hsm3-interacting domain (HA-Rpt2 75-166 , Fig. 1d ). HA-Rpt2 75-166 was not detectable when expressed alone (Fig. 6a, left panel) . However it became detectable and stable on coexpression of the Rpt1-RNC (Fig. 6a, right panel) and was detected in ribosome-containing fractions of a sucrose gradient (Supplementary Fig. 4c ). It also co-purified with the Rpt1-RNC ( Supplementary Fig. 4d ), indicating that it had been recruited to the Rpt1-RNC. These findings support our model suggesting the co-translational association of the N-terminal domains of Rpt1 and Rpt2.
Emerging from our model, that translation of Rpt1 and Rpt2 occurs with ribosome pausing, thus allowing the N-terminal α -helices of Rpt1 and Rpt2 to interact, is the idea that association of the helices might in turn signal the paused ribosomes to continue translation elongation. We tested this idea with our artificial constructs and analyzed whether the interaction of HA-Rpt2 75-166 with the Rpt1-RNC shown above ( Supplementary Fig. 4d ) altered the stalling efficacy of the K12 sequence. Indeed, the V5 epitope present after K12 in Rpt1-RNC was not detectable when the nascent Rpt1 was expressed alone, but it became detectable following coexpression of HA-Rpt2 (Fig. 6b) . Rpt1-RNC was mainly detected in the ribosome-containing fractions with similar sedimentation patterns, whether or not HA-Rpt2 was coexpressed (Fig. 6c) .
Evidence for Not1-containing assemblysomes. To explore and visualize the Not1-containing dense bodies induced following Rpt1 or Rpt2 synthesis, we considered that human cells would allow better resolution in immuno-localization experiments. The structural organization of the proteasome base ATPase subunits is well conserved between yeast and mammalian cells 27 . Moreover, we noted evidence for ribosome pausing on PSMC2-encoding human Rpt1 from published ribosome profiles 29 , at a position that should expose the conserved Rpt2-interacting helix of Rpt1 ( Supplementary  Fig. 5a ). We also noted that CNOT1, the ortholog of yeast Not1, was recruited to heavy bodies under conditions of arsenite stress where Rpt1 and Rpt2 co-translational assembly was promoted ( Supplementary Fig. 5b,c) .
We followed CNOT1 localization in human LNCaP prostate cancer cells, before and after arsenite treatment, by immunofluorescence. We observed some punctate localization of CNOT1 in cells before arsenite stress, in addition to weak diffuse staining in the cytoplasm (Fig. 7a) . Staining with a classical stress granule marker, G3BP1 (red) 30 showed diffuse staining in the cytoplasm. Following arsenite stress, the smaller distinctive bodies of CNOT1 increased in number and were brighter. Stress granules with G3BP1 became evident, but CNOT1 was mostly absent from those granules (Fig. 7a) . Similar CNOT1 particles were induced by a number of different TE F 40S 60S M P1 P2 TE F 40S 60S M P1 P2  TE F 40S 60S M P1 P2 TE F 40S 60S M P1 P2   +CHX  +EDTA  +CHX  +EDTA  MW(kDa) MW(kDa) stresses and also by proteasome inhibitor MG132 ( Supplementary  Fig. 6a ). The CNOT1 particles were not sensitive to CHX treatment that completely prevented the formation of stress granules following arsenite stress, as evidenced by G3BP1 staining ( Supplementary  Fig. 6b ). The localization of CNOT1 after arsenite treatment was compared to that of another stress granule marker, YB-1 ( Supplementary  Fig. 6c ), and to that of GW182 (marker for GW-bodies), DDX6 or Dcp1a (markers for P-bodies) ( Supplementary Fig. 6d ), but CNOT particles were mostly distinct from these messenger RNP complexes. Similar CNOT1 particles were induced by arsenite in a number of different cell lines (Supplementary Fig. 6e ).
We used single molecular RNA fluorescence in situ hybridization to determine whether Rpt1-and Rpt2-encoding mRNAs colocalized with CNOT1 particles. Indeed, after arsenite treatment we observed colocalization of CNOT1 with both Rpt1-and Rpt2-encoding mRNAs (Fig. 7b and Supplementary Fig. 6f,g ). Moreover, the Rpt1-and Rpt2-encoding mRNAs themselves colocalized (Fig. 7c) . This colocalization was also observed under pretreatment of cells with CHX ( Supplementary Fig. 6h ). Finally, to determine whether CNOT1 is necessary for the colocalization of Rpt1-and Rpt2-encoding mRNAs, we knocked down CNOT1 before arsenite treatment. Arsenite still induced the formation of stress granules, but the mRNAs encoding Rpt1 and Rpt2 now mostly did not colocalize ( Fig. 7c and Supplementary Fig. 6i,j) .
Thus, small CNOT1 particles containing Rpt1-and Rpt2-encoding mRNAs are induced following proteotoxic stress in mammalian cells, and these are neither stress granules nor GWor P-bodies. Instead, they are consistent with the Not1-containing bodies of Rpt1 and Rpt2 co-translational assembly that we observed in yeast. For this reason, we have chosen to name them Not1-containing-assemblysomes (NCA).
Discussion
Rpt1 and Rpt2 assemble co-translationally. In this work, yeast ribosome profiling data strongly suggest that the translation of proteasome RPT1 and RPT2 mRNAs occurs with ribosome pausing to allow helices in the exposed nascent peptides to associate co-translationally (see model in Fig. 8) . We support this model by showing that ribosome pausing is conserved in human cells, in which we also show that the mRNAs encoding Rpt1 and Rpt2 colocalize. We further suggest that interaction of nascent peptides is a signal for translation elongation to proceed after ribosome pausing. The expression of HA-Rpt2 was significantly different when cells expressed ProtA-Rpt1-AA compared with ProtA-Rpt1-DP (t test, P = 0.013). The data shown are representative of more than three independent experiments; the blots for the quantified duplicates and a biological triplicate are provided in Supplementary Dataset 1. MW is molecular weight.
The idea that co-translation assembly of proteins could be widespread was initially proposed in 2011 (ref. 12 ). Recently, the Bukau laboratory, using ribosome profiling, has suggested that cotranslational subunit engagement with partner proteins is prevalent 13 . They also provide evidence that this process often occurs unidirectionally, with one fully synthesized subunit engaging with its nascent partner subunit. Here we reveal a different mechanism that can ensure the productive assembly of proteins in the crowded eukaryotic cytoplasm. This mechanism entails colocalization of the mRNAs encoding partner subunits in Not1-containing granules; ribosome pausing to expose interaction domains of partner subunits outside of the ribosome tunnel; association of the interaction domains; and translation elongation. This mechanism might be useful in particular for proteins that do not readily associate when produced separately, as is the case for Rpt1 and Rpt2.
Ribosome pausing needs more than just a pause site. The ribosome pausing identified in this work occurs at the DP motifs of RPT1 and RPT2. By aligning the mRNAs encoding the yeast proteasome base subunits and the mRNA encoding human Rpt1, and their amino acid sequences, we noted that the DP motif at position 165 of Rpt2 is conserved in Rpt1, Rpt4, Rpt6, and in human Rpt1 ( Supplementary  Fig. 7 ). Nevertheless, a marked pause was detectable in our data only at the paralogous codon in Rpt6 (position 131). Not all DP codons show ribosome footprint accumulation, and it is not clear whether this is because not all sites correspond to ribosome pausing or whether footprint accumulation requires more than just ribosome pausing, such as formation of heavy particles with the corresponding RNCs. We also noted that the same K12 stalling sequence introduced in different mRNAs did not show the same efficacy of ribosome stalling. This supports the idea that actual ribosome pausing requires more than just a pause site. Moreover, we showed that productive interaction of the exposed nascent peptide with its partner allowed translation elongation through the K12 sequence. Hence, the availability and ease with which a protein can associate with its partner nascent peptide might also define whether pausing can be detected. Although we reached these conclusions using RNCs stalled with an artificial K12 sequence, we expect that ribosome pausing at DP codons or other pause sites of endogenous mRNAs is probably similarly regulated.
Not1-containing assemblysomes. We refer to the particles in which Rpt1 and Rpt2 mRNAs colocalize as NCA, because we propose that they enforce co-translational assembly of Rpt1 and Rpt2. Besides co-localizing mRNAs encoding partner subunits, NCA might also limit new translation initiation on paused RNCs, thereby avoiding ribosome collision and ribosome quality control 31 and giving time for the partner subunits to associate. They might also concentrate factors necessary for folding, pausing and thereafter translation elongation. We expect that the composition and properties of NCA might evolve during the different steps of the process.
Translation of RPT1 or RPT2 mRNAs will produce full-length proteins even without productive co-translational interaction of the nascent peptides. However, the protein produced without a partner and released into NCA is unstable. Hence, NCA might also ensure that proteins which have not associated with their partner are degraded and do not aggregate in the cytoplasm (see model on Fig. 8 ).
It will be interesting to determine whether Not1 plays any roles beyond colocalization of mRNAs in NCA. Not1 might contribute to repressing translation initiation in the NCA, since it is the scaffold of the Ccr4-Not complex that can contribute to translation repression when tethered to mRNAs (for review, see ref.
15
). At present we do not know whether Not1 in NCA functions as part of a Ccr4-Not complex. We have begun to address the role of other Ccr4-Not subunits in NCA and, to date, have found no evidence for a role of the deadenylase Ccr4 or its ortholog CNOT6. In yeast, Ccr4 deletion had no impact on the expression or stability of Rpt1-RNC, and in LNCaP cells treated with arsenite we observed little staining with antibodies to CNOT6 and no evidence for colocalization of CNOT6 with the Rpt1-and Rpt2-encoding mRNAs ( Supplementary Fig. 8a,b) . In contrast, Rpt1-RNCs were unstable in yeast cells lacking Not4 or Not5 (Supplementary Fig. 8c ) which, in the case of Not4, is consistent with its described importance in proteasome assembly and integrity 14, 32 . Our knowledge of the presence and role of Ccr4-Not components in different granules remains limited. In yeast, the Not proteins have been detected in P-bodies in a decapping mutant 33 , and mutation of the Not1 interaction domain of the Dhh1 ATPase was shown to prevent P-body disassembly 34 . In HeLa cells, CNOT2 depletion alters Ccr4-Not complex integrity and disrupts P-bodies but it is not a structural component of P-bodies 35 , whereas in male gonocytes CNOT3 can be recruited to P-bodies by Nanos2 (ref. 36 ). Ccr4 and Caf1 have been detected in P-bodies in mammalian cells 37, 38 , and also in specific mutants and/or conditions in yeast, although in yeast they did not seem to greatly impact P-body formation 39 .
Many RNA functions are undertaken in membrane-less organelles of varying size, composition and function. The exchange of components between the cytoplasm and such organelles can be direct, dynamic and reversible. They are often referred to as RNA granules and are formed by well-controlled transitions from dispersed soluble RNA and protein to a condensed state [40] [41] [42] . NCAs are likely to be such granules. The next challenge will be to characterize their protein and RNA content, their physical-chemical nature and to define their interchangeability with other messenger RNPs and RNA granules. An important question will be whether Not1 particles are specific to proteasomes or also apply to other protein complexes, and how that specificity is determined. Not1 is important for the co-translational assembly of the largest subunit of RNA polymerase II with its chaperone 43 , and for subunits of the Spt-AdaGcn5-acetyltransferase histone 18 . Hence it seems probable that Not1 will be relevant for co-translational assembly of other proteins.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability, and associated accession codes are available at https://doi.org/10.1038/ s41594-018-0179-5. In response to proteotoxic stress, proteasome mRNAs were induced and translation initiated. Top, for RPT1 and RPT2 mRNAs, ribosomes pause and the RNCs are assembled into Not1-containing particles where they are stable. The stability of the RNCs is dependent on their following their disordered N-terminal domains, and allows Rpt1-RNC and Rpt2-RNC particles to fuse (bottom right). Colocalization of the Rpt1-and Rpt2-encoding mRNAs requires Not1. The N-terminal domains of Rpt1 and Rpt2 can assemble co-translationally and translation can proceed, leading to productive interaction of Rpt1 and Rpt2 and, ultimately, the formation of proteasome. If the nascent Rpt1 and Rpt2 do not assemble, synthesis of Rpt1 and/or Rpt2 will occur separately (bottom left) and the proteins will not productively associate but instead will be degraded.
Methods
Yeast strains, plasmids, oligonucleotides and antibodies. All strains, plasmids and oligonucleotides used in this work are listed in Supplementary Table 2 . Antibodies were either commercial or previously described 44 and are also listed in Supplementary Table 2 . Proteasome and other proteins were expressed from plasmids under control of the inducible CUP1 promoter (350 nt). Full-length Rpt1 and Rpt2, or truncated versions, contain an N-terminal HA 7 tag as do N-terminal fragments of Rpt2. All clones were obtained by the drag and drop procedure 45 . Truncated stalled proteins contain a triple Flag tag at the N terminus. All encoding sequences are cloned with an (AAAAAG) 6 stalling sequence at the 3′ end, followed by an XhoI site, and 45 codons including a V5-His6 sequence before a stop codon. The plasmid expressing Protein A-tagged Rpt1 was recovered from MY6277 and sequenced. RPT1 with the 241 GAT 242 CCA codons was changed to 241 GCG 242 GCG by PCR amplification and cloned in the same plasmid backbone. Cells transformed with plasmids containing CUP1 promoter-driven genes were grown to exponential phase and induced for 10 min with 0.1 mM CuSO 4 . CHX was used at a concentration of 100 μ g ml -1 . Media were standard.
Immunoprecipitation and affinity purification. A total of 100 A 600 units of cells were broken with 0.3 ml of glass beads in 0.4 ml of lysis buffer (20 mM Hepes, pH 7.5, 20 mM KCl, 10 mM MgCl 2 , 0.1% Triton X-100, 1 mM dithiothreitol, 1 mM phenylmethanesulfonyl fluoride and a protease inhibitor cocktail) for 15 min at 4 °C. After clarification, 0.8 ml of the supernatant containing 4 mg of total protein were incubated with 1 µ g anti-Flag, anti-HA or anti-Myc antibodies and 30 µ l of protein G magnetic beads (Dynabeads, Thermo Fisher Scientific) for 5 h. The beads were washed three times with 0.8 ml of lysis buffer then incubated for 10 min at 65 °C with SDS sample buffer before SDS-PAGE and immunoblotting.
Rpt1-RNC purification.
To purify Rpt1-RNC we used the FLAG(R) Immunoprecipitation Kit (SIGMA, FLAGIPT1-1KT) and released Rpt1-RNC from the IgG beads with the Flag peptide according to the manufacturer's instructions.
Rpn11 purification.
To purify Rpn11 and associated proteins 46 , 1 l of cells grown to A 600 of 3.0 in the media selective for the plasmids were collected in 2 ml lysis buffer (50 mM Tris-Cl, pH 8.0, 5 mM MgCl 2 , 1 mM EDTA, a protease inhibitor cocktail, and 1 mM adenosine triphosphate (ATP)) and frozen by drops in liquid nitrogen. Cells were then broken in liquid nitrogen using the Retsch CryoMill 400 to form a powder. Cell powder (10 ml) was thawed by the addition of lysis buffer to 50 ml, with 0.5 ml of 100 mM ATP at 4 °C. After clarification at 4,000 rpm for 10 min at 4 °C, the lysate was further clarified by ultracentrifugation in a Beckmann Ti70 at 40,000 rpm for 30 min. The clarified lysate was filtered through 125 mM Whatman filters (no. 10311644, GE Healthcare) and the protein concentration evaluated by Bradford assay. IgG beads (0.15 ml IgG 100 mg -1 total protein; IgG sepharose fast flow, GE Healthcare) were washed with water then with lysis buffer. 10 ml of extract (10 mg ml -1 ) were added to the beads and incubated for 2 h at 4 °C. The beads and extract were loaded on a column, and the column dried by gravity. The column was washed with 50 bead volumes of buffer 2 (50 mM Tris-Cl pH 7.5, 100 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA, 1 mM ATP) and 15 bead volumes of Tobacco etch virus buffer (50 mM Tris-Cl, pH 7.5, 5 mM MgCl 2 , 1 mM EDTA, 1 mM ATP and 1 mM dithiothreitol), and dried by gravity flow. One bead volume of Tobacco etch virus buffer and 100 units of AcTEV protease (Life technologies at Thermo Fisher, Cat. no. 12575015) 100 μ l -1 of buffer were incubated with the beads in the column for 1 h at 30 °C, with mixing every 10 min. The eluate was recovered by gravity flow. The beads were washed twice with one bead volume of Tobacco etch virus buffer and the eluates were combined. Glycerol was added to a final concentration of 10%, and the eluates were concentrated using microcon tubes (Amicon Ultra-2 Centrifugal Filter Unit, EMD Millipore, Cat. no. UFC205024) to a final volume of 100 μ l.
Polysome fractionation. Extracts were fractionated in sucrose gradients as described previously 47 . CHX was added when indicated at 0.1 mg ml -1 . For immunoprecipitation, polysome fractions were combined and incubated with anti-HA, anti-Flag or anti-Myc antibodies as previously described 47 . When indicated, polysomes were disrupted by treatment of extracts with 25 mM EDTA or 10 μ g ml -1 RNase A for 5 min at room temperature before sucrose gradient fractionation.
Immunoblot quantification. Immunoblots were quantified, based on signals originating from biologically duplicated experiments, with Fiji software 48 .
Ribosome profiling. Ribosome profiling was performed for WT cells (MY3415) in biological duplicates as described previously 49 . Briefly, cells were grown to exponential phase, total extracts prepared in the presence of CHX (0.1 mg ml -1 ) were treated with RNase I, and monosomes were isolated after sucrose gradient separation. Libraries were made from the ribosome-protected fragments and subjected to deep sequencing. The positions of the P-sites on the ribosomes were deduced from deep-sequencing data in the following way. Adapters were trimmed from the 3′ end of the reads using cut_adapt utility while discarding all reads without a valid adapter. To further improve alignment, one nucleotide was removed from the 5′ end of each read (if this nucleotide is left, it is aligned erroneously in the majority of reads because it frequently represents an untemplated addition during reverse transcription 50 ). Trimmed reads were aligned to the April 2011 (sacCer3) Saccharomyces cerevisiae genome assembly from the University of California, Santa Cruz 51 . Alignment was performed by Tophat aligner using the gene annotations from the Saccharomyces Genome Database (www.yeastgenome.org) 52 in '-nonnovel-juncs' mode. Optionally, filtering of the ribosomal RNA can be performed before the alignment step, which speeds up the processing without affecting the alignments for protein-coding genes. Detection of ribosome pausing was performed in the following way: (1) P-sites were obtained from the reads by shifting the reads by a fixed amount for each read length (shift by 11, 12, 13, 12 nucleotides for ribosome protected fragment reads of length 27, 28, 29, 30, respectively) . The amount of offset was determined by observing the position of the peak at the start of the open reading frame for the given nucleotide length. (2) Counts were combined for each codon in the reading frame, thus allowing for the reduction of systematic difference between the nucleotides in the codon, as well as the observed three-nucleotide periodicity, and making the algorithm less sensitive to errors in regard to the position of one nucleotide. (3) For each gene, the distribution of the counts for all codons was individually modeled by a negative binomial distribution. (4) For each codon the ratio of its count to the average over the gene, and the P value according to the fitted negative binomial distributions, were obtained. These two numbers allow the quantification of the level of pausing and its statistical reliability. False discovery correction for multiple testing is then applied to obtain the false discovery rate-corrected Q-values. To validate the performance of our algorithm against more deeply sequenced ribosome profiling data, and to ensure that detected peaks were not simply due to heterogeneous coverage resulting from fragment sequence bias [53] [54] [55] , we downloaded data from two publicly available datasets which included matched RNA-seq and ribosome profiling samples (Gene Expression Omnibus accession nos. GSE63789 and GSE53268). We ran our algorithm on both the WT RNA-seq and ribosome-profiling samples from each dataset. In all cases, the algorithm detected many more statistically significant (adjusted P < 0.01) peaks in the ribosome-profiling data than in the matched RNA-seq data (772 versus 3 and 2,250 versus 2, respectively), giving us confidence that the detected pausing events were unique to ribosome footprints.
Mammalian cell lines, polysome profiling and RNA analysis. Cell lines used in this study were LNCaP and 22Rv1 (both from the American Type Culture Collection) and V16D prostate cancer cells (from the Vancouver Prostate Center). The cells were verified as mycoplasma free and were authenticated. A549 cells derived from human lung adenocarcinoma and bearing an oncogenic mutated Knowledge Representation for Autonomous Systems 56 were used for polysome profiling followed by CNOT1 analysis, and have not been authenticated. For polysome profiling, cells were grown until 70% confluency in two 15 cm diameter Petri dishes per sample, treated or not with arsenite, scraped and lysed in lysis buffer (10 mM HEPES, 100 mM KCl, 5 mM MgCl 2 , 100 mg ml -1 cycloheximide and 2% of Triton X-100 (pH 7.4)). For CNOT1 analysis, A549 cell extracts were analyzed after fractionation on 12 ml 7-47% sucrose gradients as in ref. 43 . For RNA analyses, LNCaP prostate cancer cell extracts were used and RNasin Plus (Promega) at 0.2 units µ l -1 was added in extracts before sucrose gradient fractionation. RNA was isolated from extracts, monosomes and heavy polysome fractions by TriZol reagent (Invitrogen) following the recommendations of the manufacturer. Total RNA was precipitated following the addition of 3 µ l of linear acrylamide (Fermentas). Pellets were resuspended in H 2 O and were DNaseI treated (RQ1 RNase-free DNase, Promega), then RNA concentration was measured by nanodrop. For qPCR analysis, 500 ng of total RNA obtained from monosomes, polysomes or total extracts were reverse transcribed with Moloney murine leukemia virus RT and oligo(dT) primers in a total volume of 25 μ l. After synthesis, cDNAs were diluted to a final volume of 250 μ l or 5 μ l and used for qPCR with gene-specific primers as described in ref. 43 . Gene-specific primer sequences are listed in Supplementary Table 2 . Relative mRNA abundances were determined by the Pfaffl method 57 and normalized to WT RNA levels. EIF4A2 mRNA was used as a loading control.
Immunofluorescence and in situ hybridization. For imaging, LNCaP, 22Rv1 and V16D cells were seeded at 20-25% confluence in 6-cm culture dishes containing round coverglasses (Fisher Scientific, 12CIR-1D). LNCaP cells were treated with siControl (Control siRNA-A; sc-37007 from Santa Cruz) or siCNOT1 (CNOT1 (h)-PR; sc-93370-PR from Santa Cruz) siRNAs for 3 d. Cells were then treated with vehicle alone or exposed to arsenite (100 μ M) for 1 h. Immunofluorescence was carried out as described previously 58 . For the localization of Rpt1-and Rpt2-encoding mRNAs in NCA, in situ hybridization was performed as described previously 58 with 56-FAM-or 5TEX615-oligos as described in Supplementary  Table 2 . The cells were then counterstained with CNOT1 antibodies as described. Cells processed as above were immersed in DRAQ5 (10 µ M, Biostatus) for nuclear staining, mounted with FluorSave and viewed using a Nikon Eclipse Ti-E inverted confocal microscope at × 40 and × 100 oil-immersion objectives. Images were captured using EZ-C1 software and were further processed using ImageJ software.
Validation of peak-calling algorithm. To validate the specificity of our algorithm for identification of peaks in ribosome footprinting data, we ran it against published data that had higher coverage than ours, good-quality measures and a matched total RNA-seq sample. In the matched ribosome footprinting data, 2,250 codons had stalling even at a high stringency cutoff (logQ < − 2, Q being the false discovery rate-corrected P value) while only two codons of the total RNA-seq data passed the same cutoff. This validated that the algorithm was identifying patterns of accumulation that specifically occur in ribosome footprints, rather than heterogenous transcript coverage due to sequence or fragment biases, which could also be present in the RNA-seq data.
Statistics and reproducibility.
All experiments presented in the manuscript were performed at least in biological triplicate with similar results, with the exception of Supplementary Fig. 5b (biological duplicates) and Supplementary Fig. 5c (single  experiment) . To analyze the significance of the difference in expression of HA-Rpt2 between cells expressing ProtA-Rpt1-DP and ProtA-Rpt1-AA, the 2 h and overnight time points were pooled and a linear model was fitted (R 2 = 0.84), with expression as dependent variable and two binary explanatory variables indicating condition (AA/DP) and time (2 h/overnight), respectively. The condition coefficient estimated a statistically significant 29.4% expression increase (95% confidence interval 
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Data collection
Microscopy: Images were captured using Nikon Eclipse Ti-E inverted confocal microscope at 40X and 100X oil-immersion objectives, for RT-qPCR microsoft excel was used. The Ribosome profiling was deposited under SRA accession: SRP134678 Temporary Submission ID: SUB3767347.
Data analysis
Microscopy: Images were captured using EZ-C1 software and were further processed using ImageJ software, for RT-qPCR Excel was used.The analysis for the ribosome profiling is accessible at the web site: https://github.com/fedxa/RiboPeaks.
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